Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Q: What does CUSIP 05280R100 represent in this 13F holders report?

CUSIP 05280R100 is the security identifier for AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share used to aggregate holder disclosures.

Q: How many institutions held AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in Q3 2023?

67 institutional investors reported AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 05280R100

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Shares outstanding: 265,957,447
Total 13F shares: 110,707,409
Share change: +1,372,950
Total reported value: $257,962,960
Put/Call ratio: 0%
Price per share: $2.33
Number of holders: 67
Value change: +$2,926,164
Number of buys: 19
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 05280R100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Syncona Portfolio Ltd	13F	Company	8%	21,346,829	$50,805,453	—	30 Jun 2023	13F
Blackstone Inc.	13F	Company	7.7%	20,485,611	$48,755,754	—	30 Jun 2023	13F
Deep Track Capital, LP	13F	Company	5.6%	15,000,000	$35,700,000	—	30 Jun 2023	13F
Tetragon Partners GP Ltd	13F	Company	4.5%	12,000,000	$28,560,000	—	30 Jun 2023	13F
Paradigm Biocapital Advisors LP	13F	Company	3.5%	9,217,150	$21,936,817	—	30 Jun 2023	13F
ARMISTICE CAPITAL, LLC	13F	Company	2.7%	7,264,000	$17,288,320	—	30 Jun 2023	13F
Nantahala Capital Management, LLC	13F	Company	1.6%	4,272,203	$10,167,843	—	30 Jun 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	1.4%	3,746,857	$8,917,520	—	30 Jun 2023	13F
Perpetual Ltd	13F	Company	0.75%	1,996,355	$4,751,325	—	30 Jun 2023	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.63%	1,672,732	$3,981,102	—	30 Jun 2023	13F
Affinity Asset Advisors, LLC	13F	Company	0.6%	1,589,017	$3,781,860	—	30 Jun 2023	13F
Laurion Capital Management LP	13F	Company	0.56%	1,500,000	$3,570,000	—	30 Jun 2023	13F
DAFNA Capital Management LLC	13F	Company	0.35%	930,394	$2,214,338	—	30 Jun 2023	13F
BlackRock Finance, Inc.	13F	Company	0.33%	870,994	$2,072,966	—	30 Jun 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.29%	777,760	$1,851,000	—	30 Jun 2023	13F
Alphabet Inc.	13F	Company	0.26%	698,262	$1,661,863	—	30 Jun 2023	13F
Odey Asset Management LLP	13F	Company	0.25%	658,995	$1,568,408	—	30 Jun 2023	13F
LGT CAPITAL PARTNERS LTD.	13F	Company	0.21%	550,000	$1,309,000	—	30 Jun 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.2%	530,919	$1,263,587	—	30 Jun 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.2%	519,442	$1,236,272	—	30 Jun 2023	13F
MAI Capital Management	13F	Company	0.15%	401,496	$955,560	—	30 Jun 2023	13F
Cormorant Asset Management, LP	13F	Company	0.15%	392,167	$933,357	—	30 Jun 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.12%	308,787	$734,913	—	30 Jun 2023	13F
Ikarian Capital, LLC	13F	Company	0.1%	260,087	$619,006	—	30 Jun 2023	13F
HARBOR CAPITAL ADVISORS, INC.	13F	Company	0.09%	244,541	$582,008	—	30 Jun 2023	13F
Erste Asset Management GmbH	13F	Company	0.07%	195,000	$444,600	—	30 Jun 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.07%	185,815	$442,240	—	30 Jun 2023	13F
EDENTREE ASSET MANAGEMENT Ltd	13F	Company	0.07%	180,000	$430,200	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	0.06%	160,314	$381,547	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	151,200	$360,000	—	30 Jun 2023	13F
Cetera Investment Advisers	13F	Company	0.05%	135,200	$321,776	—	30 Jun 2023	13F
ALPS ADVISORS INC	13F	Company	0.05%	127,220	$302,784	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	112,945	$268,809	—	30 Jun 2023	13F
Mariner, LLC	13F	Company	0.04%	101,000	$240,000	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	93,195	$221,804	—	30 Jun 2023	13F
Leonteq Securities AG	13F	Company	0.03%	75,000	$178,500	—	30 Jun 2023	13F
UBS Group AG	13F	Company	0.03%	70,093	$166,821	—	30 Jun 2023	13F
Privium Fund Management B.V.	13F	Company	0.03%	67,577	$154,076	—	30 Jun 2023	13F
INNOVIS ASSET MANAGEMENT LLC	13F	Company	0.02%	63,179	$150,367	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	0.02%	52,387	$124,681	—	30 Jun 2023	13F
EXCHANGE TRADED CONCEPTS, LLC	13F	Company	0.02%	49,527	$117,874	—	30 Jun 2023	13F
LPL Financial LLC	13F	Company	0.02%	48,675	$115,847	—	30 Jun 2023	13F
WEALTH EFFECTS LLC	13F	Company	0.02%	47,000	$111,860	—	30 Jun 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.01%	27,215	$64,772	—	30 Jun 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.01%	26,400	$62,832	—	30 Jun 2023	13F
MARSHALL WACE, LLP	13F	Company	0.01%	25,496	$60,681	—	30 Jun 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	25,376	$60,395	—	30 Jun 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	23,265	$55,371	—	30 Jun 2023	13F
B. Riley Wealth Advisors, Inc.	13F	Company	0.01%	22,000	$52,360	—	30 Jun 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.01%	21,907	$52,139	—	30 Jun 2023	13F

Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q3 2023

As of 30 Sep 2023, Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 110,707,409 shares. The largest 10 holders included Syncona Portfolio Ltd, Blackstone Inc., Deep Track Capital, LP, Paradigm Biocapital Advisors LP, TFG Asset Management GP Ltd, ARMISTICE CAPITAL, LLC, Frazier Life Sciences Management, L.P., Affinity Asset Advisors, LLC, Perpetual Ltd, and SCHRODER INVESTMENT MANAGEMENT GROUP. This page lists 68 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.